Acute Coronary Stent Thrombosis in Modern Era: Etiology, Treatment, and Prognosis

Junhua Ge1, Haichu Yu, Jian Li

  • 1Department of Cardiology, Affiliated Hospital of Qingdao University, Qingdao, China.

Cardiology
|May 5, 2017
PubMed

Insights

Acute stent thrombosis (AST), a rare but serious complication of coronary stenting, presents ongoing challenges. This review covers AST

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Science

Background:

  • Acute stent thrombosis (AST) is a rare, life-threatening complication following coronary artery stenting.
  • Despite advances in techniques and therapies, AST remains a significant clinical challenge for cardiologists.

Purpose of the Study:

  • To provide a comprehensive overview of acute stent thrombosis.
  • To discuss the prevalence, risk factors, prognosis, and pathogenesis of AST.
  • To identify knowledge gaps and recommend diagnostic and management strategies for AST.

Main Methods:

  • This review synthesizes current literature on acute stent thrombosis.
  • It examines epidemiological data, etiological factors, and clinical outcomes.
  • Diagnostic criteria and therapeutic approaches are critically evaluated.

Main Results:

  • AST, though infrequent, carries a high mortality and morbidity rate.
  • Multiple factors contribute to AST, including patient-related, stent-related, and procedural elements.
  • Current management strategies aim to mitigate risks but require further refinement.

Conclusions:

  • Effective management of AST necessitates a thorough understanding of its complex pathophysiology.
  • Individualized diagnostic and treatment strategies are crucial for improving patient outcomes.
  • Further research is needed to address existing knowledge gaps in AST prevention and treatment.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
347
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
523
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
570